Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies

References

• Abdallah, A. E., Alesawy, M. S., Eissa, S. I., El-Fakharany, E. M., Kalaba, M. H., Sharaf, M. H., Abo Shama, N. M., Mahmoud, S. H., Mostafa, A., Al-Karmalawy, A. A., & Elkady, H. (2021). Karmalawy, design and synthesis of new 4-(2-nitrophenoxy) benzamide derivatives as potential antiviral agents: Molecular modeling and in vitro antiviral screening. New Journal of Chemistry, 45(36), 16557–16571. https://doi.org/10.1039/D1NJ02710G
   Web of Science ®Google Scholar
• Abdel-Wahab, B. F., & Khidre, R. E. (2013). 2-Chloroquinoline-3-carbaldehyde II: Synthesis, reactions, and applications. Journal of Chemistry, 2013, 1–13. https://doi.org/10.1155/2013/851297
   Web of Science ®Google Scholar
• Abdel-Aziz, H. A., Eldehna, W. M., Fares, M., Al-Rashood, S. T., Al Rashood, K. A., Abdel-Aziz, M. M., & Soliman, D. H.,. (2015). Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. International Journal of Molecular Sciences, 16(12), 8719–8743. https://doi.org/10.3390/ijms16048719
   PubMedGoogle Scholar
• Abou-Seri, S. M., Eldehna, W. M., Ali, M. M., & Abou El Ella, D. A. (2016). 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation. European Journal of Medicinal Chemistry, 107, 165–179. https://doi.org/10.1016/j.ejmech.2015.10.053
   PubMed Web of Science ®Google Scholar
• Alanazi, M. M., Elkady, H., Alsaif, N. A., Obaidullah, A. J., Alanazi, W. A., Al-Hossaini, A. M., Alharbi, M. A., Eissa, I. H., & Dahab, M. A. (2022). Discovery of new quinoxaline-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: Design, synthesis, and in silico study. Journal of Molecular Structure, 1253, 132220. https://doi.org/10.1016/j.molstruc.2021.132220
   Web of Science ®Google Scholar
• Alanazi, M. M., Elkady, H., Alsaif, N. A., Obaidullah, A. J., Alkahtani, H. M., Alanazi, M. M., Alharbi, M. A., Eissa, I. H., & Dahab, M. A. (2021). New quinoxaline-based VEGFR-2 inhibitors: Design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies. RSC Advances, 11(48), 30315–30328. https://doi.org/10.1039/d1ra05925d
   PubMed Web of Science ®Google Scholar
• Alesawy, M. S., Elkaeed, E. B., Alsfouk, A. A., Metwaly, A. M., & Eissa, I. H. (2021). In silico screening of semi-synthesized compounds as potential inhibitors for SARS-CoV-2 papain-like protease: Pharmacophoric features, molecular docking, ADMET, toxicity and DFT studies. Molecules, 26(21), 6593. https://doi.org/10.3390/molecules26216593
   PubMed Web of Science ®Google Scholar
• Alsaif, N. A., Dahab, M. A., Alanazi, M. M., Obaidullah, A. J., Al-Mehizia, A. A., Alanazi, M. M., Aldawas, S., Mahdy, H. A., & Elkady, H. (2021a). New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorganic Chemistry, 110, 104807. https://doi.org/10.1016/j.bioorg.2021.104807
   PubMed Web of Science ®Google Scholar
• Alsaif, N. A., Taghour, M. S., Alanazi, M. M., Obaidullah, A. J., Al-Mehizia, A. A., Alanazi, M. M., Aldawas, S., Elwan, A., & Elkady, H. (2021b). Discovery of new VEGFR-2 inhibitors based on bis ([1, 2, 4] triazolo)[4, 3-a: 3', 4'-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 1093–1114. https://doi.org/10.1080/14756366.2021.1915303
   PubMed Web of Science ®Google Scholar
• Arranz-Valsero, I., Soriano-Romaní, L., García-Posadas, L., López-García, A., & Diebold, Y. (2014). IL-6 as a corneal wound healing mediator in an in vitro scratch assay. Experimental Eye Research, 125, 183–192. https://doi.org/10.1016/j.exer.2014.06.012
   PubMed Web of Science ®Google Scholar
• Aziz, N. A., George, R. F., El-Adl, K., & Mahmoud, W. R. (2022). Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2, 4-diones bearing heterocyclic rings as dual VEGFR-2/EGFR T790M tyrosine kinase inhibitors. RSC Advances, 12(20), 12913–12931. https://doi.org/10.1039/d2ra01119k
   PubMed Web of Science ®Google Scholar
• Belal, A., Abdel Gawad, N. M., Mehany, A. B., Abourehab, M. A., Elkady, H., Al‐Karmalawy, A. A., & Ismael, A. S. (2022). Design, synthesis and molecular docking of new fused 1 H-pyrroles, pyrrolo [3, 2-d] pyrimidines and pyrrolo [3, 2-e][1, 4] diazepine derivatives as potent EGFR/CDK2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 1884–1902. https://doi.org/10.1080/14756366.2022.2096019
   PubMedGoogle Scholar
• Belal, A., Elanany, M. A., Santali, E. Y., Al-Karmalawy, A. A., Aboelez, M. O., Amin, A. H., Abdellattif, M. H., Mehany, A. B., & Elkady, H. (2022). Screening a panel of topical ophthalmic medications against MMP-2 and MMP-9 to investigate their potential in keratoconus management. Molecules, 27(11), 3584. https://doi.org/10.3390/molecules27113584
   PubMed Web of Science ®Google Scholar
• Belal, A., Elkady, H., Al-Karmalawy, A. A., Amin, A. H., Ghoneim, M. M., El-Sherbiny, M., Al-Serwi, R. H., Abdou, M. A., Ibrahim, M. H., & Mehany, A. B. (2022). Discovery of some heterocyclic molecules as bone morphogenetic protein 2 (BMP-2)-inducible kinase inhibitors: Virtual screening, ADME properties, and molecular docking simulations. Molecules, 27(17), 5571. https://doi.org/10.3390/molecules27175571
   PubMed Web of Science ®Google Scholar
• Best, R. B., Zhu, X., Shim, J., Lopes, P. E., Mittal, J., Feig, M., & Mackerell, A. D. Jr., (2012). Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone phi, psi and side-chain chi(1) and chi(2) dihedral angles. Journal of Chemical Theory and Computation, 8(9), 3257–3273. https://doi.org/10.1021/ct300400x
   PubMed Web of Science ®Google Scholar
• BIOVIA, QSAR, ADMET and Predictive Toxicology. (2020). https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html
   Google Scholar
• Borenfreund, E., & Puerner, J. A. (1985). Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicology Letters, 24(2–3), 119–124. https://doi.org/10.1016/0378-4274(85)90046-3
   PubMed Web of Science ®Google Scholar
• Brooks, B. R., Brooks, C. L., III, Mackerell, A. D., Jr., Nilsson, L., Petrella, R. J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S., Caflisch, A., Caves, L., Cui, Q., Dinner, A. R., Feig, M., Fischer, S., Gao, J., Hodoscek, M., Im, W., Kuczera, K., Lazaridis, T., Ma, J., Ovchinnikov, V., Paci, E., Pastor, R. W., Post, C. B., Pu, J. Z., Schaefer, M., Tidor, B., Venable, R. M., Woodcock, H. L., Wu, X., Yang, W., York, D. M., … Karplus, M. (2009). CHARMM: The biomolecular simulation program. Journal of Computational Chemistry, 30(10), 1545–1614. https://doi.org/10.1002/jcc.21287
   PubMed Web of Science ®Google Scholar
• Bruno, G., Costantino, L., Curinga, C., Maccari, R., Monforte, F., Nicolo, F., Ottana, R., & Vigorita, M. (2002). Synthesis and aldose reductase inhibitory activity of 5-arylidene-2, 4-thiazolidinediones. Bioorganic & Medicinal Chemistry, 10(4), 1077–1084. https://doi.org/10.1016/S0968-0896(01)00366-2
   PubMed Web of Science ®Google Scholar
• Cree, I. A., & Charlton, P. (2017). Molecular chess? Hallmarks of anti-cancer drug resistance. BMC Cancer, 17(1), 1–8. https://doi.org/10.1186/s12885-016-2999-1
   PubMedGoogle Scholar
• Eissa, I. H., El-Helby, A.-G A., Mahdy, H. A., Khalifa, M. M., Elnagar, H. A., Mehany, A. B. M., Metwaly, A. M., Elhendawy, M. A., Radwan, M. M., ElSohly, M. A., & El-Adl, K. (2020). Discovery of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorganic Chemistry, 105, 104380. https://doi.org/10.1016/j.bioorg.2020.104380
   PubMed Web of Science ®Google Scholar
• Eissa, I. H., Ibrahim, M. K., Metwaly, A. M., Belal, A., Mehany, A. B., Abdelhady, A. A., Elhendawy, M. A., Radwan, M. M., ElSohly, M. A., & Mahdy, H. A. (2021). Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorganic Chemistry, 107, 104532. https://doi.org/10.1016/j.bioorg.2020.104532
   PubMed Web of Science ®Google Scholar
• El-Adl, K., El-Helby, A.-G A., Ayyad, R. R., Mahdy, H. A., Khalifa, M. M., Elnagar, H. A., Mehany, A. B. M., Metwaly, A. M., Elhendawy, M. A., Radwan, M. M., ElSohly, M. A., & Eissa, I. H. (2021). Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors. Bioorganic & Medicinal Chemistry, 29, 115872. https://doi.org/10.1016/j.bmc.2020.115872
   PubMed Web of Science ®Google Scholar
• El-Adl, K., Ibrahim, M.-K., Alesawy, M. S., & Eissa, I. H. [ (2021). 1, 2, 4] Triazolo [4, 3-c] quinazoline and bis ([1, 2, 4] triazolo)[4, 3-a: 4′, 3′-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorganic & Medicinal Chemistry, 30, 115958. https://doi.org/10.1016/j.bmc.2020.115958
   PubMed Web of Science ®Google Scholar
• El-Adl, K., Sakr, H. M., Yousef, R. G., Mehany, A. B., Metwaly, A. M., Elhendawy, M. A., Radwan, M. M., ElSohly, M. A., Abulkhair, H. S., & Eissa, I. H. (2021). Discovery of new quinoxaline-2 (1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorganic Chemistry, 114, 105105. https://doi.org/10.1016/j.bioorg.2021.105105
   PubMed Web of Science ®Google Scholar
• El-Deeb, N. M., Ibrahim, O. M., Mohamed, M. A., Farag, M. M., Farrag, A. A., & El-Aassar, M. (2022). Alginate/κ-carrageenan oral microcapsules loaded with Agaricus bisporus polysaccharides MH751906 for natural killer cells mediated colon cancer immunotherapy. International Journal of Biological Macromolecules, 205, 385–395. https://doi.org/10.1016/j.ijbiomac.2022.02.058
   PubMed Web of Science ®Google Scholar
• Eldehna, W. M., El Hassab, M. A., Abo-Ashour, M. F., Al-Warhi, T., Elaasser, M. M., Safwat, N. A., Suliman, H., Ahmed, M. F., Al-Rashood, S. T., Abdel-Aziz, H. A., & El-Haggar, R. (2021). Development of isatin-thiazolo [3, 2-a] benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations. Bioorganic Chemistry, 110, 104748. https://doi.org/10.1016/j.bioorg.2021.104748
   PubMed Web of Science ®Google Scholar
• Eldehna, W. M., El Hassab, M. A., Elsayed, Z. M., Al-Warhi, T., Elkady, H., Abo-Ashour, M. F., Abourehab, M. A., Eissa, I. H., & Abdel-Aziz, H. A. (2022). Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity. Scientific Reports, 12(1), 1–13. https://doi.org/10.1038/s41598-022-15050-8
   PubMed Web of Science ®Google Scholar
• El‐Helby, A. G. A., Sakr, H., Eissa, I. H., Abulkhair, H., Al‐Karmalawy, A. A., & El‐Adl, K. (2019). Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors. Archiv Der Pharmazie, 352(10), 1900113. https://doi.org/10.1002/ardp.201900113
   Web of Science ®Google Scholar
• El-Helby, A.-G. A., Ayyad, R. R., El-Adl, K., & Elkady, H. (2019). Phthalazine-1, 4-dione derivatives as non-competitive AMPA receptor antagonists: Design, synthesis, anticonvulsant evaluation, ADMET profile and molecular docking. Molecular Diversity, 23(2), 283–298. https://doi.org/10.1007/s11030-018-9871-y
   PubMed Web of Science ®Google Scholar
• Elkady, H., Elwan, A., El-Mahdy, H. A., Doghish, A. S., Ismail, A., Taghour, M. S., Elkaeed, E. B., Eissa, I. H., Dahab, M. A., Mahdy, H. A., & Khalifa, M. M. (2022). New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 397–410. https://doi.org/10.1080/14756366.2021.2015343
   PubMed Web of Science ®Google Scholar
• Elkaeed, E. B., Eissa, I. H., Elkady, H., Abdelalim, A., Alqaisi, A. M., Alsfouk, A. A., Elwan, A., & Metwaly, A. M. (2022). A multistage in silico study of natural potential inhibitors targeting SARS-CoV-2 main protease. International Journal of Molecular Sciences, 23(15), 8407. https://doi.org/10.3390/ijms23158407
   PubMed Web of Science ®Google Scholar
• Elkaeed, E. B., Elkady, H., Belal, A., Alsfouk, B. A., Ibrahim, T. H., Abdelmoaty, M., Arafa, R. K., Metwaly, A. M., & Eissa, I. H. (2022). Multi-phase in silico discovery of potential SARS-CoV-2 RNA-dependent RNA polymerase inhibitors among 3009 clinical and FDA-approved related drugs. Processes, 10(3), 530. https://doi.org/10.3390/pr10030530
   Web of Science ®Google Scholar
• Elkaeed, E. B., Yousef, R. G., Elkady, H., Gobaara, I. M., Alsfouk, A. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2022). The assessment of anticancer and VEGFR-2 inhibitory activities of a new 1H-indole derivative: In silico and in vitro approaches. Processes, 10(7), 1391. https://doi.org/10.3390/pr10071391
   Web of Science ®Google Scholar
• Elkaeed, E. B., Yousef, R. G., Elkady, H., Gobaara, I. M., Alsfouk, B. A., Husein, D. Z., Ibrahim, I. M., Metwaly, A. M., & Eissa, I. H. (2022). Design, synthesis, docking, DFT, MD simulation studies of a new nicotinamide-based derivative: In vitro anticancer and VEGFR-2 inhibitory effects. Molecules, 27(14), 4606. https://doi.org/10.3390/molecules27144606
   PubMed Web of Science ®Google Scholar
• Elkaeed, E. B., Youssef, F. S., Eissa, I. H., Elkady, H., Alsfouk, A. A., Ashour, M. L., El Hassab, M. A., Abou-Seri, S. M., & Metwaly, A. M. (2022). Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease. International Journal of Molecular Sciences, 23(13), 6912. https://doi.org/10.3390/ijms23136912
   PubMed Web of Science ®Google Scholar
• El-Metwally, S. A., Abou-El-Regal, M. M., Eissa, I. H., Mehany, A. B., Mahdy, H. A., Elkady, H., Elwan, A., & Elkaeed, E. B. (2021). Discovery of thieno [2, 3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorganic Chemistry, 112, 104947. https://doi.org/10.1016/j.bioorg.2021.104947
   PubMed Web of Science ®Google Scholar
• El-Naggar, A. M., Eissa, I. H., Belal, A., & El-Sayed, A. A. (2020). Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site. RSC Advances, 10(5), 2791–2811. https://doi.org/10.1039/C9RA10094F
   PubMed Web of Science ®Google Scholar
• Elwan, A., Abdallah, A. E., Mahdy, H. A., Dahab, M. A., Taghour, M. S., Elkaeed, E. B., Mehany, A. B. M., Nabeeh, A., Adel, M., Alsfouk, A. A., Elkady, H., & Eissa, I. H. (2022). Modified benzoxazole-based VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, and anti-proliferative evaluation. Molecules, 27(15), 5047. https://doi.org/10.3390/molecules27155047
   PubMed Web of Science ®Google Scholar
• El-Zahabi, M. A., Elbendary, E. R., Bamanie, F. H., Radwan, M. F., Ghareib, S. A., & Eissa, I. H. (2019). Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists. Bioorganic Chemistry, 91, 103115. https://doi.org/10.1016/j.bioorg.2019.103115
   PubMed Web of Science ®Google Scholar
• El-Zahabi, M. A., Sakr, H., El-Adl, K., Zayed, M., Abdelraheem, A. S., Eissa, S. I., Elkady, H., & Eissa, I. H. (2020). Design, synthesis, and biological evaluation of new challenging thalidomide analogs as potential anticancer immunomodulatory agents. Bioorganic Chemistry, 104, 104218. https://doi.org/10.1016/j.bioorg.2020.104218
   PubMed Web of Science ®Google Scholar
• Evdokimov, N. M., Magedov, I. V., McBrayer, D., & Kornienko, A. (2016). Isatin derivatives with activity against apoptosis-resistant cancer cells. Bioorganic & Medicinal Chemistry Letters, 26(6), 1558–1560. https://doi.org/10.1016/j.bmcl.2016.02.015
   PubMed Web of Science ®Google Scholar
• Imieje, V. O., Zaki, A. A., Metwaly, A. M., Mostafa, A. E., Elkaeed, E. B., & Falodun, A. (2021). Comprehensive in silico screening of the antiviral potentialities of a new humulene glucoside from Asteriscus hierochunticus against SARS-CoV-2. Journal of Chemistry, 2021, 1–14. (). https://doi.org/10.1155/2021/5541876
   Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865.
   PubMed Web of Science ®Google Scholar
• Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002). Dominant‐negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S‐S dependent homodimerization. International Journal of Cancer, 97(5), 626–630. https://doi.org/10.1002/ijc.10100
   PubMed Web of Science ®Google Scholar
• Kar, K., Krithika, U., Basu, P., Santhosh Kumar, S., Reji, A., Prashantha Kumar., & B. R., Mithuna. (2014). Design, synthesis and glucose uptake activity of some novel glitazones. Bioorganic Chemistry, 56, 27–33. https://doi.org/10.1016/j.bioorg.2014.05.006
   PubMed Web of Science ®Google Scholar
• Koch, A., Tamez, P., Pezzuto, J., & Soejarto, D. (2005). Evaluation of plants used for antimalarial treatment by the Maasai of Kenya. Journal of Ethnopharmacology, 101(1–3): 95–99. https://doi.org/10.1016/j.jep.2005.03.011
   PubMed Web of Science ®Google Scholar
• Kumar, K., Anbarasu, A., & Ramaiah, S. (2014). Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins. Molecular bioSystems, 10(4), 891–900. https://doi.org/10.1039/c3mb70537d
   PubMedGoogle Scholar
• Kuzmanic, A., & Zagrovic, B. (2010). Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophysical Journal, 98(5), 861–871. https://doi.org/10.1016/j.bpj.2009.11.011
   PubMed Web of Science ®Google Scholar
• Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., Wei, S., Buckner, J., Jeong, J. C., Qi, Y., Jo, S., Pande, V. S., Case, D. A., Brooks, C. L., MacKerell, A. D., Klauda, J. B., & Im, W. (2016). CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. Journal of Chemical Theory and Computation, 12(1), 405–413. https://doi.org/10.1021/acs.jctc.5b00935
   PubMed Web of Science ®Google Scholar
• Léonce, S., Pérez, V., Lambel, S., Peyroulan, D., Tillequin, F., Michel, S., Koch, M., Pfeiffer, B., Atassi, G., Hickman, J. A., & Pierré, A. (2001). Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis. Molecular Pharmacology, 60(6), 1383–1391. https://doi.org/10.1124/mol.60.6.1383
   PubMed Web of Science ®Google Scholar
• Li, N., Wang, Y., Li, W., Li, H., Yang, L., Wang, J., Mahdy, H. A., Mehany, A. B. M., Jaiash, D. A., Santali, E. Y., & Eissa, I. H. (2020). Screening of some sulfonamide and sulfonylurea derivatives as anti-Alzheimer’s agents targeting BACE1 and PPARγ. Journal of Chemistry, 2020, 1–19. https://doi.org/10.1155/2020/1631243
   Web of Science ®Google Scholar
• Liu, P., Lu, J., Yu, H., Ren, N., Lockwood, F. E., & Wang, Q. J. (2017). Lubricant shear thinning behavior correlated with variation of radius of gyration via molecular dynamics simulations. The Journal of Chemical Physics, 147(8), 84904. https://doi.org/10.1063/1.4986552
   PubMed Web of Science ®Google Scholar
• Liu, X., Shi, D., Zhou, S., Liu, H., Liu, H., & Yao, X. (2018). Molecular dynamics simulations and novel drug discovery. Expert Opinion on Drug Discovery, 13(1), 23–37. https://doi.org/10.1080/17460441.2018.1403419
   PubMed Web of Science ®Google Scholar
• Lugano, R., Ramachandran, M., & Dimberg, A. (2020). Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cellular and Molecular Life Sciences, 77(9), 1745–1770. https://doi.org/10.1007/s00018-019-03351-7
   PubMed Web of Science ®Google Scholar
• Mahdy, H. A., Ibrahim, M. K., Metwaly, A. M., Belal, A., Mehany, A. B. M., El-Gamal, K. M. A., El-Sharkawy, A., Elhendawy, M. A., Radwan, M. M., Elsohly, M. A., & Eissa, I. H. (2020). Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Bioorganic Chemistry, 94, 103422. https://doi.org/10.1016/j.bioorg.2019.103422
   PubMed Web of Science ®Google Scholar
• Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmaceutical Bulletin, 7(3), 339–348. https://doi.org/10.15171/apb.2017.041
   PubMed Web of Science ®Google Scholar
• Marrone, T. J., Briggs, a., James, M., & McCammon, J. A. (1997). Structure-based drug design: Computational advances. Annual Review of Pharmacology and Toxicology, 37(1), 71–90. https://doi.org/10.1146/annurev.pharmtox.37.1.71
   PubMedGoogle Scholar
• Mohammed, S. O., El Ashry, E. S. H., Khalid, A., Amer, M. R., Metwaly, A. M., Eissa, I. H., Elkaeed, E. B., Elshobaky, A., & Hafez, E. E. (2022). Expression, purification, and comparative inhibition of helicobacter pylori urease by regio-selectively alkylated benzimidazole 2-thione derivatives. Molecules, 27(3), 865. https://doi.org/10.3390/molecules27030865
   PubMed Web of Science ®Google Scholar
• NHS, Cancer. (2022). https://www.nhs.uk/conditions/cancer/. (Accessed 27-1-2022).
   Google Scholar
• Papageorgis, P., Cheng, K., Ozturk, S., Gong, Y., Lambert, A. W., Abdolmaleky, H. M., Zhou, J.-R., & Thiagalingam, S. (2011). Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Cancer Research, 71(3), 998–1008. https://doi.org/10.1158/0008-5472.CAN-09-3269
   PubMed Web of Science ®Google Scholar
• Parmar, D. R., Soni, J. Y., Guduru, R., Rayani, R. H., Kusurkar, R. V., Vala, A. G., Talukdar, S. N., Eissa, I. H., Metwaly, A. M., Khalil, A., Zunjar, V., & Battula, S. (2021). Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorganic Chemistry, 115, 105206. https://doi.org/10.1016/j.bioorg.2021.105206
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kale, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Shi, L., Zhou, J., Wu, J., Shen, Y., & Li, X. (2016). Anti-angiogenic therapy: Strategies to develop potent VEGFR-2 tyrosine kinase inhibitors and future prospect. Current Medicinal Chemistry, 23(10), 1000–1040. https://doi.org/10.2174/0929867323666160210130426
   PubMed Web of Science ®Google Scholar
• Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2006). Protein–ligand docking: Current status and future challenges. Proteins: Structure, Function, and Bioinformatics, 65(1), 15–26. https://doi.org/10.1002/prot.21082
   PubMed Web of Science ®Google Scholar
• Suleimen, Y. M., Jose, R. A., Suleimen, R. N., Arenz, C., Ishmuratova, M. Y., Toppet, S., Dehaen, W., Alsfouk, B. A., Elkaeed, E. B., Eissa, I. H., & Metwaly, A. M. (2022). Jusanin, a new flavonoid from artemisia commutata with an in silico inhibitory potential against the SARS-CoV-2 main protease. Molecules, 27(5), 1636. https://doi.org/10.3390/molecules27051636
   PubMed Web of Science ®Google Scholar
• Suleimen, Y. M., Jose, R. A., Suleimen, R. N., Arenz, C., Ishmuratova, M., Toppet, S., Dehaen, W., Alsfouk, A. A., Elkaeed, E. B., Eissa, I. H., & Metwaly, A. M. (2022). Isolation and in silico anti-SARS-CoV-2 papain-like protease potentialities of two rare 2-phenoxychromone derivatives from Artemisia spp. Molecules, 27(4), 1216. https://doi.org/10.3390/molecules27041216
   PubMed Web of Science ®Google Scholar
• Suleimen, Y. M., Metwaly, A. M., Mostafa, A. E., Elkaeed, E. B., Liu, H.-W., Basnet, B. B., Suleimen, R. N., Ishmuratova, M. Y., Turdybekov, K. M., & Van Heсke, K. (2021). Isolation, crystal structure, and in silico aromatase inhibition activity of ergosta-5, 22-dien-3β-ol from the fungus Gyromitra esculenta. Journal of Chemistry, 2021, 1–10. https://doi.org/10.1155/2021/5529786
   Web of Science ®Google Scholar
• Taghour, M. S., Elkady, H., Eldehna, W. M., El-Deeb, N. M., Kenawy, A. M., Elkaeed, E. B., Alsfouk, A. A., Alesawy, M. S., Metwaly, A. M., & Eissa, I. H. (2022). Design and synthesis of thiazolidine-2, 4-diones hybrids with 1, 2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 1903–1917.
   PubMed Web of Science ®Google Scholar
• Taghour, M. S., Mahdy, H. A., Gomaa, M. H., Aglan, A., Eldeib, M. G., Elwan, A., Dahab, M. A., Elkaeed, E. B., Alsfouk, A. A., Khalifa, M. M., Eissa, I. H., & Elkady, H. (2022). Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and antiproliferative evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry, 37(1), 2063–2077. https://doi.org/10.1080/14756366.2022.2103552
   PubMed Web of Science ®Google Scholar
• Thabrew, M. I., Hughes, R. D., & McFarlane, I. G. (1997). Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. The Journal of Pharmacy and Pharmacology, 49(11), 1132–1135. https://doi.org/10.1111/j.2042-7158.1997.tb06055.x
   PubMed Web of Science ®Google Scholar
• Vasan, N., Baselga, J., & Hyman, D. M. (2019). A view on drug resistance in cancer. Nature, 575(7782), 299–309. https://doi.org/10.1038/s41586-019-1730-1
   PubMed Web of Science ®Google Scholar
• WHO, Cancer. (2022). https://www.who.int/news-room/fact-sheets/detail/cancer. (Accessed 26-1-2022).
   Google Scholar
• Xia, X., Maliski, E. G., Gallant, P., & Rogers, D. (2004). Classification of kinase inhibitors using a Bayesian model. Journal of Medicinal Chemistry, 47(18), 4463–4470. https://doi.org/10.1021/jm0303195
   PubMed Web of Science ®Google Scholar
• Yousef, R. G., Sakr, H. M., Eissa, I. H., Mehany, A. B., Metwaly, A. M., Elhendawy, M. A., Radwan, M. M., ElSohly, M. A., Abulkhair, H. S., & El-Adl, K. (2021). New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New Journal of Chemistry, 45(36), 16949–16964. https://doi.org/10.1039/D1NJ02509K
   Web of Science ®Google Scholar
• Yu, Y.-C., Kuang, W.-B., Huang, R.-Z., Fang, Y.-L., Zhang, Y., Chen, Z.-F., & Ma, X.-L. (2017). Design, synthesis and pharmacological evaluation of new 2-oxo-quinoline derivatives containing α-aminophosphonates as potential antitumor agents. MedChemComm, 8(6), 1158–1172. https://doi.org/10.1039/c7md00098g
   PubMed Web of Science ®Google Scholar
• Zucchini, N., de Sousa, G., Bailly-Maitre, B., Gugenheim, J., Bars, R., Lemaire, G., & Rahmani, R. (2005). Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes. Biochimica et Biophysica Acta, 1745(1), 48–58. https://doi.org/10.1016/j.bbamcr.2005.02.005
   PubMed Web of Science ®Google Scholar